Mi‐Jung Kang

Statistics

Publications

Citations

216

H-Index

Active since

2019

Affiliations

Korea Research Institute of Bioscience and Biotechnology(Current)

Korea University of Science and Technology

Genome Research Foundation

Yonsei University

Sungkyunkwan University

Mi‐Jung Kang is an author at Korea Research Institute of Bioscience and Biotechnology specializing in oncology, signal transduction in cancer, and molecular oncology.

Publications per year

2019–2024

Publications

DDIAS promotes STAT3 activation by preventing STAT3 recruitment to PTPRM in lung cancer cells

Joo‐Young Im, Bo‐Kyung Kim, Kang‐Woo Lee et al. · Oncogenesis · 2020 · 52 citations · Full text

Life Sciences, Cell Biology, Oncology +17

PI3K/AKT/β-Catenin Signaling Regulates Vestigial-Like 1 Which Predicts Poor Prognosis and Enhances Malignant Phenotype in Gastric Cancer

Bo‐Kyung Kim, Jae‐Ho Cheong, Joo‐Young Im et al. · Cancers · 2019 · 30 citations · Full text

Medicine, Cancer Biology, Oncology +17

Licochalcone A inhibits hypoxia-inducible factor-1α accumulation by suppressing mitochondrial respiration in hypoxic cancer cells

Min Kyung Park, Jun Ji, Keeok Haam et al. · Biomedicine & Pharmacotherapy · 2020 · 30 citations · Full text

Medicine, Oncology, Pharmacology +17

Synaptotagmin 11 scaffolds MKK7–JNK signaling process to promote stem-like molecular subtype gastric cancer oncogenesis

Bo‐Kyung Kim, Da-Mi Kim, Hyunkyung Park et al. · Journal of Experimental & Clinical Cancer Research · 2022 · 30 citations · Full text

Medicine, Molecular Biology, Oncology +17

VGLL1 phosphorylation and activation promotes gastric cancer malignancy via TGF-β/ERK/RSK2 signaling

Joo‐Young Im, Da-Mi Kim, Hyunkyung Park et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 2020 · 22 citations · Full text

Medicine, Cell Biology, Oncology +17

1–5 of 8